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The rising rate of opioid-related deaths across Canada has been an ongoing and significant national 
public health crisis for over a decade.1 In just the first three months of 2020, there were 1,018 opioid-
related deaths recorded in Canada, the vast majority of which (96%) were accidental.2 In the midst 
of this ongoing crisis, the emergence of the COVID-19 pandemic in Ontario led to the provincial 
declaration of a state of emergency on March 17, 2020.3 Within Ontario, the first wave of the pandemic 
was addressed with public health restrictions to mitigate the spread of COVID-19, which included 
physical distancing measures that resulted in reduced capacity for pharmacies, outpatient clinics, and 
harm reduction sites providing care to people who use drugs. Despite the intention to reduce the 
impact of COVID-19, there is concern that these measures could lead to unintended harms.4 
In June 2020, Ontario’s Chief Coroner announced a 25% increase in suspected drug-related deaths 
between March and May 2020, compared to the monthly median reported in 2019.5 Similar trends have 
been reported elsewhere in Canada.6 It is expected that this increase in drug-related deaths is being 
driven by a combination of numerous factors, including an increasingly toxic unregulated (‘street’) 
drug supply, barriers to access to harm reduction services and treatment, and physical distancing 
requirements leading to more people using drugs alone.4,5
Understanding the circumstances that contribute to these deaths is urgently needed to inform 
interventions and policies to prevent opioid-related mortality in the midst of the COVID-19 pandemic.
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Background
The data contained in this report was obtained by the Office of the Chief Coroner/Ontario Forensic 
Pathology Service (OCC/OFPS) during investigations of confirmed and suspected opioid-related 
deaths in Ontario. An opioid-related death is defined as an acute intoxication/toxicity death resulting 
from the direct contribution of consumed substance(s), where one or more of the substances was an 
opioid, regardless of how the opioid was obtained.7 Suspected opioid-related deaths are defined on 
the basis of evidence of drug use or drug paraphernalia found at the scene and/or signs of drug use 
and an opioid detected in post-mortem toxicology, but where a final conclusion on the cause of death is 
pending. On May 1, 2017, the OCC/OFPS launched the Opioid Investigative Aid (OIA) which resulted 
in a standardized database of information regarding the circumstances surrounding opioid-related 
deaths. The OIA is completed by the investigating coroner using a combination of sources (e.g., health 
records, family, bystanders, emergency responders), and captures demographic information as well as 
details related to the location of the incident, post-mortem toxicology results, and other circumstances 
surrounding the death. The cause and manner of death are determined by the death investigation and 
post-mortem examinations by pathologists and captured in the OIA. In order to rapidly report on factors 
related to opioid-related deaths during the pandemic, some OIA are not yet complete, and in some 
circumstances cause and manner of death have not been confirmed. Therefore, the denominators for 
variables reported throughout the report differ according to data availability. More details can be found 
in the Appendix.
Trends in opioid-related deaths over time were reported according to epi-weeks (Monday – Sunday), 
and stratified according to whether the death was confirmed or suspected as opioid-related. For 
the purposes of comparing circumstances surrounding deaths, we defined March 16, 2020 as the 
‘beginning’ of the pandemic as this was the beginning of the epi-week during which Ontario declared an 
emergency order related to the COVID-19 pandemic (March 17, 2020). The pandemic cohort included 
deaths from March 16, 2020 to June 30, 2020 and the pre-pandemic cohort from December 1, 2019 to 
March 15, 2020. We used chi-squared tests and the Fisher’s exact test where appropriate to compare 
proportions between cohorts, and the Cochrane-Armitage test to identify trends in quintile distributions. 
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Methods Overview
Weekly number of opioid-related deaths in Ontario prior to, and during, 
the COVID-19 pandemic
Trends in Opioid-Related Deaths
The number of opioid-related deaths increased quickly in the weeks 
following the state of emergency declaration in Ontario on March 17, 
2020. Overall, there was a 38.2% increase in opioid-related deaths in 
the first 15 weeks of the COVID-19 pandemic (695 deaths; average 
of 46 deaths weekly) compared to the 15 weeks immediately prior 
(503 deaths; average of 34 deaths weekly). 
If the number of opioid-related deaths continues to increase at the 
weekly pandemic rate for the rest of 2020, it is anticipated that there 
will be 2,271 opioid-related deaths in the province by the end of the 
year. This would represent a 50% increase from the year prior (1,512 
opioid-related deaths in 2019).
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As some of the investigations are 
still underway, the number of opioid-
related deaths that are suspected is 
higher in May and June 2020. After the 
investigation has been finalized, it is 
possible that the investigating coroner 
will determine some of these deaths 
are not opioid-related. Similarly, 
although rare, there may be other 
opioid-related deaths that occurred 
during this period that are not captured 
in the figure above as they have not yet 
been determined to be opioid-related 
by the investigating coroner.
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The remainder of this report compares circumstances of opioid-related deaths occurring in Ontario 
during the following two periods:
Pre-Pandemic Cohort
December 1, 2019 - March 15, 2020 
(n=519)
Pandemic Cohort
March 16, 2020 - June 30, 2020 
(n=705)
Distribution of opioid-related deaths by age
Although there has been no change in the distribution of opioid-related deaths by age during the pandemic, 
the largest absolute increases in deaths occurred among people aged 25 to 44 (289 vs. 389, pre-pandemic 
vs. during pandemic) and those aged 45 to 64 (176 vs. 242, pre-pandemic vs. during pandemic). Overall, 
89.5% of all opioid-related deaths occurring during the pandemic were among these age groups. Although 
the absolute increase was relatively small, the number of opioid-related deaths among those aged 65+ 
more than doubled during the pandemic.
During the pandemic, there has been a statistically 
significant shift towards opioid-related deaths occurring 
more commonly among men. Specifically, 69.7% of 
deaths (362 of 519) in the pre-pandemic cohort were 
among men, rising to 78.0% of deaths (550 of 705) in the 
pandemic cohort (p<0.01).
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The proportion of men among opioid-related 
deaths increased from:
78%70%
pre-pandemic
during the 
pandemic
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Distribution of opioid-related deaths by neighbourhood quintile of a) 
material deprivation and b) ethnic diversity* 
There was a strong clustering of opioid-related deaths in neighbourhoods with the highest material 
deprivation, both before and during the pandemic. In contrast, during the pandemic, there was a significant 
trend towards more opioid-related deaths occurring in neighbourhoods with a higher ethno-cultural diversity. 
This trend was not observed in the pre-pandemic period, and is concerning as data emerges demonstrating 
that ethnically diverse neighbourhoods, particularly those in large urban centres, are also experiencing 
higher rates of COVID-19 infection and related death.8 
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1) * Using the Ontario Marginalization Index. 
2) 42 individuals had missing information and are not captured in this figure.
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a)
b)
Manner of death among confirmed cases
The vast majority of confirmed opioid-related deaths in Ontario continue to be accidental in nature. Since 
the pandemic emerged, growth in confirmed deaths has been concentrated among accidental deaths, with 
an absolute increase of 127 accidental deaths in the pandemic cohort compared to the pre-pandemic cohort 
(p<0.01). There were 88 suspected opioid-related deaths in the pandemic cohort where manner of death 
has not yet been determined, and therefore the observed decrease in deaths determined to be intentional 
(suicide) may not be reliable as investigations for potentially intentional deaths may take longer to complete.
* Indicates statistically significant difference in proportions between cohorts
NOTE
*
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Location of incident among opioid-related deaths prior to, and during, 
the pandemic
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During the pandemic, there have been changes in the location of incidents leading to opioid-related deaths, 
with a significantly lower percentage of opioid-related deaths occurring in public indoor spaces (3.1% vs. 
0.7%), and a higher percentage of deaths occurring outdoors (3.9% vs. 7.8%). However, the findings related 
to outdoor location should be interpreted with caution as this may be influenced by the pandemic period 
occurring during the spring months, compared to the pre-pandemic cohort occurring during the winter 
months. When comparing the pandemic cohort to the same period one year prior (March 16 – June 30 
2019), to account for seasonality, there was no significant difference in the percentage of deaths occurring 
outdoors (8.6% vs. 7.8%). 
There was also a trend towards more deaths occurring in hotels, motels, or inns (24 [4.7%] vs. 41 [6.1%], pre-
pandemic vs. during the pandemic). Although this was not statistically significant, this should be monitored 
due to the movement of people in some cities into hotels as supportive housing or isolation centres (if 
infected with COVID-19 or a close contact of an infected individual) during the pandemic.9,10
1) * indicates statistically significant difference in proportions between cohorts. 
2) “Public indoor spaces” includes commercial/retail buildings or public buildings, such as train/bus stations. “Other” includes 
correctional institutes, parking garages, and churches. 
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Individual present who could intervene
During the pandemic, among opioid-related deaths where this 
information was available, nearly three-quarters of deaths occurred 
when no one was present to intervene (N=363 of 492; 73.8%). This 
increased slightly compared to the period prior to the pandemic, 
although the increase was not statistically significant (N=261 of 366, 
71.3% pre-pandemic). Information on whether an individual was 
present was not available for approximately one-quarter of opioid-
related deaths both prior to (28.7%) and during (26.5%) the pandemic.
In three out of four deaths during 
the pandemic, no one was 
present to intervene.
Patterns of resuscitation attempts
There was a non-statistically significant observation of fewer resuscitation attempts and less naloxone 
administration among people who died of an opioid-related cause during the pandemic. When naloxone 
was administered, it was more commonly administered by a bystander (60% vs. 48%), and less commonly 
administered by a first responder (51% vs. 54%) or in a hospital setting (25% vs. 35%) during the pandemic 
compared to the pre-pandemic period. This may reflect patterns of people being more likely to be alone at 
time of opioid toxicity described previously in this report, reduced access to harm reduction (e.g., overdose 
prevention and supervised consumption and treatment services), and lower rates of naloxone dispensing 
through pharmacies observed early in the pandemic.14
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Likely mode of drug use based on coroner’s investigation
During the pandemic, there has been a significant shift towards opioid-related deaths with evidence of a 
pipe/foil for inhalation at the scene, with approximately one-third of deaths having indication of supplies for 
inhalation (N=222, 33.2%; p=0.01). However, this trend follows a pattern of increasing evidence of inhalation 
as a potential mode of drug use that has been observed among deaths in Ontario [data not shown] and 
British Columbia over the past few years.11 Therefore, it is not clear if this trend is due to circumstances 
related to the pandemic or a continuation of pre-existing trends towards more inhalation of drugs.12,13 
Drug paraphernalia found at the scene may provide proxy information for potential mode of drug use, but may also reflect previous 
modes of use or paraphernalia that was used by someone else. Drug paraphernalia other than syringe, pipe, and foil may have 
been found at scene (e.g. grinder, spoon). When no pipe, foil or evidence of injection drug use is present, mode may include oral, 
nasal, transdermal, other or unknown modes of drug use.
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Geographic location of incident among opioid-related deaths 
There was no change in the distribution of deaths by geographic location during the pandemic, with 
approximately two-thirds of all opioid-related deaths occurring in large urban centres. However, the largest 
absolute increases in opioid-related deaths were observed in medium (N=29) and large (N=127) urban 
centres in Ontario.
There were 9 deaths in the pre-pandemic cohort and 22 deaths in the pandemic cohort where the geographic location of the death 
was unknown.
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Opioids directly contributing to opioid-related deaths in Ontario
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During the pandemic, fentanyl was more commonly a direct contributor to opioid related deaths (87.2% 
[N=538 of 617]) compared to the pre-pandemic cohort; (79.2% [N=399 of 504]; p<0.01). There was also a 
decline in methadone involvement (from 13.3% [N=67] to 9.2% [N=57]; p=0.03) during the pandemic. These 
findings may be reflective of changes in the unregulated drug supply and changing access to prescription 
opioids observed early in the pandemic, which may have led to an increased reliance on unregulated drug 
supplies, and the increasing toxicity of the unregulated (‘street’) drug supply available.14 Importantly, there 
was no indication of increased involvement of fentanyl analogues (e.g., carfentanil) during the pandemic.
1) * indicates statistically significant difference in proportions between cohorts. 
2) ** Other includes tramadol, oxymorphone, and hydrocodone. 
3) *** Fentanyl estimates include fentanyl analogues. However, there were only 4 and 10 deaths attributed to fentanyl analogues in 
the pre-pandemic and pandemic cohorts, respectively. 
4) Some deaths may be attributed to multi-drug toxicity where more than one substance can contribute to an individual death. 
There were 88 suspected opioid-related deaths in the pandemic cohort and 15 in the pre-pandemic cohort not included in this figure.
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Other drug involvement in opioid-related deaths
During the pandemic, there was a significant increase in the percentage of opioid-related deaths with 
stimulants as a contributing factor, rising from 52.0% (N=262) to 60.5% (N=373; p=0.01). This appears to be 
driven by cocaine involvement in deaths, which directly contributed to nearly half (45.2%) of opioid-related 
deaths during the pandemic, compared to 37.5% in the pre-pandemic cohort. Although there appeared to 
be a decrease in benzodiazepines directly contributing to deaths during the pandemic (10.1% to 5.7%; 
p=0.01), approximately one-third of deaths had a benzodiazepine detected both prior to (31.5%) and during 
(32.9%) the pandemic. Furthermore, detection of etizolam increased significantly during the pandemic, 
rising from 7.9% to 13.8% of opioid-related deaths (p<0.01). This suggests that benzodiazepines continue 
to be frequently involved in opioid-related deaths; although they may not be determined to be a major 
contributor to death by the investigating coroners.  
1) * indicates statistically significant difference in proportions between cohorts. 
2) * Other stimulants include 3,4-Methylenedioxymethamphetamine (MDMA), Methylenedioxyamphetamine (MDA), Amphetmine 
(in the absence of methamphetamine), Methylphenidate, and Pseudoephedrine.
3) There were 88 suspected opioid-related deaths in the pandemic cohort and 15 in the pre-pandemic cohort not included in this 
figure.
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Generally, the increased rate of opioid-related deaths during the pandemic has occurred throughout the 
province (see Appendix). Statistically significant higher rates were observed during the pandemic in six 
local public health units: City of Hamilton Public Health Services, North Bay Parry Sound District Health Unit, 
Ottawa Public Health, Peel Public Health, Toronto Public Health, and Wellington-Dufferin-Guelph Public 
Health. The Hamilton, Ottawa, Peel, and Toronto regions had the largest absolute increase in opioid deaths, 
reporting 22, 16, 37 and 39 additional deaths during the pandemic period compared to the pre-pandemic 
cohort, respectively. The highest rates of opioid-related deaths in the pandemic period were observed in 
Algoma Public Health, North Bay Parry Sound, Public Health Sudbury District, Peterborough Public Health, 
Niagara Region Public Health and Lambton Public Health. However, rates in regions with small populations 
should be interpreted with caution as they can be easily influenced by a small number of deaths.
1) * indicates statistically significant difference in proportions between cohorts. 
2) ** These data include confirmed and suspected- opioid related deaths and distribution of investigations still under investigation 
(i.e., suspected opioid-related deaths) may vary by region.
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Limitations
There are several limitations that require mention. First, the OCC/OFPS has not concluded all investigations 
for opioid-related deaths that occurred during the study period. Therefore, some of the data included in this 
report are preliminary and subject to change. Specifically, 12% of cases during the pandemic cohort, and 3% of 
those in the pre-pandemic cohort were suspected opioid-related deaths and the substances reported as direct 
contributors to death only reflect those identified in confirmed opioid-related deaths. Second, the circumstances 
surrounding opioid-related deaths have shifted in Ontario over the past decade, even in the absence of the 
COVID-19 pandemic. Therefore, the observed differences between the pre-pandemic cohort and the pandemic 
cohort could be attributed to the COVID-19 pandemic or may be due to pre-existing temporal changes. An 
example of this is seasonality in the location of drug use in Ontario, with fewer deaths anticipated to be outdoors 
during winter months. Information on broader comparisons have been provided where possible to help determine 
whether observed changes could be attributed to the pandemic. Third, statistics on material deprivation and 
ethnic diversity relied on the Ontario Marginalization Index which is a neighbourhood-level variable and may 
not reflect individual-level characteristics. Finally, due to relatively small population sizes and fewer case counts, 
the rates of opioid-related deaths observed in some public health units should be interpreted with caution as 
they can be influenced by small absolute changes in the number of deaths. Full data on the regional analysis of 
changes in opioid-related deaths can be found in the Appendix of this report. 
Summary of Findings
In the first 15 weeks of the COVID-19 pandemic in Ontario, 695 people died of a confirmed or suspected opioid-
related death, representing a 38% increase compared to the 15 weeks immediately preceding the pandemic. 
During the pandemic, fentanyl and stimulants (particularly cocaine) were more commonly direct contributors 
to these deaths. These findings could represent unexpected exposures to stimulants (excluding caffeine) or 
fentanyl in the drug supply (although data from drug checking services in Toronto suggests that this may not be 
the case during the pandemic)15, patterns of poly-substance use (e.g. stimulants being used to manage opioid 
withdrawal symptoms), or availability and affordability of the unregulated drug supply.16 In contrast, the significant 
increase in etizolam detection during the pandemic aligns with data from drug checking services in Toronto, 
suggesting that this synthetic benzodiazepine has increasingly been identified in fentanyl samples.15 This was 
not commonly labeled as a direct contributor to death by the investigating coroner, as there is a paucity of data 
regarding the effects of the combination of these unregulated drugs. Further understanding is needed on the 
contributions of etizolam and other synthetic benzodiazepines to opioid-related deaths. 
This report also identifies trends toward more opioid-related deaths among people who are using drugs alone, 
outdoors, and in hotel/motel settings during the pandemic. These factors are all likely influenced by pandemic-
related changes aimed to promote physical distancing measures in the province, which may have inadvertently 
reduced access to safer spaces to use drugs (e.g. supervised consumption and treatment services) and support 
networks, suggesting opportunities to prevent accidental deaths. For example, given evidence of the increasingly 
toxic unregulated drug supply during the pandemic,4 expanded access to a range of low-barrier opioid agonist 
treatments or safer supply of regulated opioids could be considered. Furthermore, harm reduction services that 
can ensure someone is present to intervene in case of opioid toxicity should be a priority of local and provincial 
governments. Although we cannot determine whether the use of hotels as supportive housing and COVID-19 
isolation centres has influenced the increased prevalence of opioid-related deaths in hotels across Ontario, this 
is a trend that warrants ongoing monitoring as it is imperative that the pandemic-related services are supported 
by harm reduction and health care partners. 
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Although relatively unchanged during the COVID-19 pandemic, opioid-related deaths continue to disproportionately 
impact men aged 25 to 44 residing in neighbourhoods with higher material deprivation (i.e., lower income, poorer 
quality of housing, lower education and higher likelihood of single-parent families).17 Importantly, during the 
pandemic, we observed a shift towards opioid-related deaths occurring more frequently within communities with 
higher concentrations of people who are recent immigrants and/or racialized.17 This parallels recent trends in 
COVID-19 infection and death rates that are increasingly being concentrated in ethnically diverse neighbourhoods 
in Ontario,8,18,19 and suggests that pandemic responses are disproportionately leading to negative impacts on 
both COVID-19 and opioid-related outcomes among racialized communities.
The geographic analysis of opioid-related deaths across Ontario shows that, while there has been a rising trend 
of opioid-related deaths across most regions of Ontario during the pandemic, some areas – particularly larger 
urban centres like Hamilton, Toronto, Ottawa and Peel regions – are exhibiting the largest increases in rates 
and absolute number of cases. Therefore, while local governments across the province should consider how to 
provide adequate services and supports to people who use drugs during the COVID-19 pandemic, this need is 
most urgent in larger urban centres across the province.
In closing, the findings of this report broadly suggest a need for policies and programs designed to urgently 
address the increase in opioid mortality, such as to provide access to harm reduction services, a range of low-
barrier opioid agonist treatment options, a safer supply of drugs, other health and social supports, and integration 
of these services into hotels used to house people during the pandemic. These recommendations align with 
those made by national organizations4 and reflect the need to act quickly to provide adequate support for people 
who use drugs during current and anticipated future waves of this pandemic.
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Ontario Drug Policy Research Network 
Contributors
The Ontario Drug Policy Research Network (ODPRN) is a province-wide network of researchers who provide 
timely, high quality, drug policy relevant research to decision makers. The ODPRN’s core principles are quality, 
relevance, and timeliness. The ODPRN conducts research to determine real-world drug utilization, safety, 
effectiveness, and costs of drugs in Ontario, and has developed partnerships that allow them to engage in cross-
provincial comparisons of drug safety and utilization. For more information, visit odprn.ca. 
Office of the Chief Coroner/Ontario Forensic Pathology Service
Together the OCC/OFPS provide death investigation services in Ontario serving the living through high quality 
investigations and inquests to ensure that no death will be overlooked, concealed or ignored. The findings 
are used to generate recommendations to help improve public safety and prevent further deaths. In Ontario, 
coroners are medical doctors with specialized training in the principles of death investigation. Coroners investigate 
approximately 17,000 deaths per year in accordance with section 10 of the Coroners Act. The OFPS provides 
forensic pathology services in accordance with the Coroners Act. It provides medicolegal autopsy services for 
public death investigations under the legal authority of a coroner. The OFPS performs approximately 7,500 
autopsies per year. For more information, visit mcscs.jus.gov.on.ca.
Public Health Ontario 
Public Health Ontario (PHO) is a Crown corporation dedicated to protecting and promoting the health of all 
Ontarians and reducing inequities in health. PHO links public health practitioners, frontline health workers 
and researchers to the best scientific intelligence and knowledge from around the world. PHO provides expert 
scientific and technical support to government, local public health units and health care providers relating to the 
following:
• communicable and infectious diseases 
• infection prevention and control 
• environmental and occupational health 
• emergency preparedness 
• health promotion, chronic disease and injury prevention 
• public health laboratory services 
PHO’s work also includes surveillance, epidemiology, research, professional development, and knowledge 
services. For more information, visit publichealthontario.ca.
Centre on Drug Policy Evaluation
The Centre on Drug Policy Evaluation (CDPE), based at St. Michael’s Hospital in Toronto, ON, strives to improve 
community health and safety by conducting research and outreach on best practices in drug policy. The CDPE 
works collaboratively with governments, affected communities, and civil society to guide effective and evidence-
based policy responses to substance use. For more information, visit cdpe.org. 
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Data Capture and Completeness
Appendix
Pre-Pandemic 
Cohort
Pandemic 
Cohort Variables included in analysis
Total Opioid-Related 
Deaths 519 705
Opioid Investigative 
Aid (OIA) 513 (99%) 669 (95%)
No OIA 6 (1%) 36 (5%)
Confirmed Opioid-
Related Deaths 504 (97%) 617 (88%)
OIA 498 (99%) 588 (95%) All variables
No OIA 6 (1%) 29 (5%)
Age group, sex, manner of death, 
substance involvement, week, public health 
unit, neighbourhood indicators
Suspected Opioid-
Related Deaths 15 (3%) 88 (12%)
OIA 15 (100%) 81 (92%)
Age group, sex, week, public health 
unit, neighborhood indicators, location 
of incident, likely mode of drug use, 
resuscitation attempts, location of incident, 
individual present who could intervene
No OIA 0 (0%) 7 (8%) Age group, sex, week, public health unit, neighbourhood indicators
The “No OIA” category reflects cases where an OIA is pending and was not available at the time of the report.
NOTE
23
Number and rate of opioid-related deaths* during the pandemic, by 
public health unit
Public Health Unit Population
Pre-Pandemic  
Cohort (N; Rate 
per 100,000)
Pandemic 
Cohort (N; Rate 
per 100,000)
P-Value
Ontario (Total) 14,634,260 519 (3.5) 705 (4.8) <0.01
Algoma Public Health 114,395 14 (12.2) 19 (16.6) 0.38
Brant County Health Unit 152,733 12 (7.9) 9 (5.9) 0.51
Chatham-Kent Public Health 105,385 4 (3.8) 6 (5.7) 0.75
City of Hamilton Public Health Services 584,765 18 (3.1) 40 (6.8) <0.01
Durham Region Health Department 701,760 27 (3.8) 24 (3.4) 0.67
Eastern Ontario Health Unit 209,678 1 (0.5) 6 (2.9) 0.13
Grey Bruce Health Unit 166,974 3 (1.8) 5 (3) 0.72
Haldimand-Norfolk Health Unit 112,101 4 (3.6) 7 (6.2) 0.55
Haliburton, Kawartha, Pine Ridge District Health 186,520 9 (4.8) 10 (5.4) 0.81
Halton Region Public Health 607,042 9 (1.5) 9 (1.5) 1.00
Hastings Prince Edward Public Health 165,588 2 (1.2) 7 (4.2) 0.18
Huron County Health Unit 138,715 2 (1.4) 2 (1.4) 1.00
Kingston, Frontenac and Lennox & Addington 
Public Health 211,243 11 (5.2) 13 (6.2) 0.68
Lambton Public Health 130,153 7 (5.4) 11 (8.5) 0.35
Leeds, Grenville & Lanark District Health Unit 171,109 0 (0) 5 (2.9) 0.06
Middlesex-London Health Unit 497,806 29 (5.8) 29 (5.8) 1.00
Niagara Region Public Health 466,255 37 (7.9) 41 (8.8) 0.65
North Bay Parry Sound District Health Unit 129,183 7 (5.4) 17 (13.2) 0.04
Northwestern Health Unit 81,963 4 (4.9) 3 (3.7) 1.00
Ottawa Public Health 1,033,679 22 (2.1) 38 (3.7) 0.04
Peel Public Health 1,569,190 26 (1.7) 63 (4.0) <0.01
Peterborough Public Health 144,431 9 (6.2) 17 (11.8) 0.12
Porcupine Health Unit 85,295 10 (11.7) 7 (8.2) 0.47
Public Health Sudbury & Districts 200,347 21 (10.5) 27 (13.5) 0.38
Region of Waterloo Public Health 571,973 23 (4.0) 24 (4.2) 0.88
Renfrew County and District Health Unit 108,422 1 (0.9) 1 (0.9) 1.00
Simcoe Muskoka District Health Unit 583,736 31 (5.3) 33 (5.7) 0.8
Southwestern 207,698 9 (4.3) 8 (3.9) 1.00
Thunder Bay District Health Unit 154,473 14 (9.1) 13 (8.4) 0.81
Timiskaming Health Unit 33,235 2 (6.0) 1 (3.0) 1.00
Toronto Public Health 3,063,359 114 (3.7) 153 (5.0) 0.02
Wellington-Dufferin-Guelph Public Health 303,466 3 (1.0) 12 (4.0) 0.04
Windsor-Essex County Health Unit 418,581 16 (3.8) 23 (5.5) 0.26
York Region Public Health 1,223,007 18 (1.5) 20 (1.6) 0.75
* Includes confirmed and suspected opioid-related deaths, the distribution of which may vary by geographic region.
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